Features & Analyses

Cindy Shuqi Zhen of Wan Hui Da Intellectual Property discusses the impact of the Third Amendment to the PRC Copyright Law, which represents the latest effort to enhance the protection of intellectual property in China

After almost a decade, Michael Jordan has finally secured a major victory in his protracted legal battle against a Chinese sportswear company over the use of his name.

Casper Sek of Jin Mao Partners highlights new draft rules that aim to curb monopolistic behavior and strengthen the administrative supervision of the internet platform economy, and standardize online petty loans businesses that use big data by imposing new requirements on internet platforms used by such businesses

The scope of China's cross-border personal information transfer regulatory regime is edging closer to being finalized, but businesses are in no rush to overhaul their data transfer practices

The draft Personal Information Protection Law introduces two new data transfer mechanisms that do not seem to directly require government approval

Coming into effect in January, China's fundamental law introduces new provisions on personal information protection and strengthens weaker parties in contractual negotiations

A Biden administration is likely to share the same export controls and sanctions policy goals as its predecessor, while taking on a more collaborative approach with stakeholders and industry

Scrutiny of Chinese investment in the U.S. is unlikely to ease anytime soon, but a Biden administration is expected to adopt a less abrasive approach than that of his predecessor

Fay Zhou, Vivian Cao and Xi Liao of Linklaters discuss the recently introduced Leniency and Commitments Guidelines by highlighting their differences in application, scope and legal implications, as well as whether companies should adopt the leniency or commitments mechanisms to seek comparatively favorable or less severe outcomes when responding to antitrust investigations

Fang Qi and Danlei Wu of Fangda Partners highlight the main provisions in the recently introduced Fourth Amendment to the PRC Patent Law, which aims to establish a patent linkage system for patents in the pharmaceuticals industry, bring about significant changes to the design patent regime, strengthen patent protection against infringement and tackle the issue of abuse of patent rights